Navigation Links
How will the US biotechnology industry benefit from new patent laws?
Date:5/1/2012

New Rochelle, NY, May 1, 2012Passage of the America Invents Act into law led to the most dramatic changes in the U.S. patent system in 60 years. These reforms will have a significant impact on technology innovators such as biotechnology-based businesses, as detailed in two articles in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc. The articles are available free online on the Industrial Biotechnology website.

"Industrial biotechnology companies rely heavily on their patents to attract investment to fund the research and development necessary to bring innovative products to consumers. Strong intellectual property protection is critical for these companies," says Brent Erickson, Consulting Editor of Industrial Biotechnology and Executive Vice President, Industrial & Environmental Section, Biotechnology Industry Organization (BIO), Washington, DC. "The Leahy-Smith America Invents Act will strengthen America's patent system and drive job growth throughout our economy. The improvements made by the bill will benefit all sectors of the national economy by enhancing patent quality and the efficiency, objectivity, predictability and transparency of the U.S. patent system. Companies will benefit from the improvements to our nation's patent system made by this legislation."

One of the most critical and far-reaching features of the America Invents Act (AIA) that will affect all U.S. patent applications filed on or after March 16, 2013 is the change from a "first-to-invent" to a "first-inventor-to-file" system. Technology specialists Tiffany Reiter, PhD and Erin Baker, PhD, and principal patent attorney J. Peter Fasse, Fish & Richardson (Boston, MA), provide a comprehensive review of the new system, describing its implications and exceptions. The authors clearly illustrate how pending and future patent applications will be affected by the new law in the article "The America Invents Act and Its Importance to Patent Prosecution in the Biotech Sector."

Sandra Thompson, JD, PhD, a specialist in intellectual property law at Buchalter Nemer (Irvine, CA), clarifies some common misunderstandings related to the new first-to-file system as well as other aspects of the AIA. In the article "The America Invents Act and Your Biotech-Based Business," Dr. Thompson explains which aspects of the AIA went into effect immediately and which will be put into practice gradually over an 18-month period, and why this knowledge is crucial for companies developing novel products and technologies.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
2. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
3. Anti-biotech groups obstruct forest biotechnology
4. New edition of ASM Press biotechnology text announced
5. NYU School of Medicine presents biomedical researchers Dart/NYU Biotechnology Achievement Awards
6. AAPS immunogenicity training course to be offered prior to national biotechnology conference
7. Biotherapeutic Innovations on Display at AAPS National Biotechnology Conference
8. Cutting-edge vaccine research to be showcased at AAPS National Biotechnology Conference
9. Success with cisgenics in forestry offers new tools for biotechnology
10. Developments in nanobiotechnology at UCSB point to medical applications
11. Advances in Optics for Biotechnology, Medicine and Surgery XII
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How will the US biotechnology industry benefit from new patent laws?
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... today reported financial results for its quarter and year ended ... quarter of 2016 was $3.9 million compared to $6.9 million ... fourth quarter of 2016 was $0.6 million compared to $2.6 ... the fourth quarter of 2016 was $0.5 million, or $0.02 ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... ... by the Connecticut Technology Council (CTC) as a 2017 Women of Innovation® finalist. ... Women of Innovation Awards Dinner. , The dinner recognizes women accomplished in science, ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
(Date:3/22/2017)... , March 22, 2017  UBM and the ... announce their extended partnership and the third annual Massachusetts ... by the 21 st Annual MassMEDIC Conference ... place May 3-4, 2017. MassMEDIC ... Association (ADVAMED) President and CEO, Scott Whitaker ...
(Date:3/22/2017)... March 22, 2017 MarketNewsUpdates.com News Commentary  ... The ... are being pressured as of late due to the rise ... management has a dramatic impact on patient,s quality of life ... activities for identifying new forms of opioid formulations that prevent ...
Breaking Biology Technology: